Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SOPH | Menu Philippe | Chief Medical Officer | 09/14/2026 | Verkauf | 7.88 | 5,000 | 39,417 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 09/14/2026 | Verkauf | 7.88 | 4,000 | 31,538 | Form 4 |
| SOPH | Van Well Daan | Chief Legal Officer | 09/11/2026 | Verkauf | 7.63 | 6,168 | 47,089 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 09/10/2026 | Verkauf | 7.66 | 8,500 | 65,120 | Form 4 |
| SOPH | Hibbs Kathy L | Director | 09/08/2026 | Verkauf | 8.13 | 6,250 | 50,818 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/27/2026 | Verkauf | 8.91 | 10,000 | 89,096 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 08/25/2026 | Verkauf | 8.68 | 5,000 | 43,397 | Form 4 |
| SOPH | Hibbs Kathy L | Director | 08/25/2026 | Verkauf | 8.68 | 6,250 | 54,233 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 08/24/2026 | Verkauf | 8.80 | 5,000 | 44,000 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/21/2026 | Verkauf | 8.40 | 5,408 | 45,447 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/20/2026 | Verkauf | 8.41 | 4,592 | 38,609 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 08/19/2026 | Verkauf | 8.20 | 5,000 | 41,000 | Form 4 |
| SOPH | Valente Manuela | Chief People Officer | 08/19/2026 | Verkauf | 7.94 | 10,000 | 79,439 | Form 4 |
| SOPH | Valente Manuela | Chief People Officer | 08/19/2026 | Optionsausübung | 3.20 | 10,000 | 32,000 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/19/2026 | Verkauf | 7.94 | 10,000 | 79,427 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/13/2026 | Verkauf | 7.52 | 4,000 | 30,076 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 08/12/2026 | Verkauf | 7.52 | 5,000 | 37,580 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 08/10/2026 | Verkauf | 7.61 | 8,500 | 64,669 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 08/07/2026 | Verkauf | 7.60 | 5,000 | 38,000 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 08/07/2026 | Verkauf | 7.23 | 20,000 | 144,540 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/07/2026 | Verkauf | 7.48 | 10,000 | 74,759 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/07/2026 | Verkauf | 7.02 | 7,000 | 49,152 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/07/2026 | Optionsausübung | 3.28 | 7,000 | 22,960 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/05/2026 | Verkauf | 7.00 | 3,000 | 21,013 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/05/2026 | Optionsausübung | 3.28 | 3,000 | 9,840 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 08/04/2026 | Verkauf | 6.95 | 5,000 | 34,772 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 08/04/2026 | Verkauf | 6.92 | 20,000 | 138,412 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/04/2026 | Verkauf | 6.92 | 10,000 | 69,168 | Form 4 |
| SOPH | Menu Philippe | Chief Medical Officer | 07/27/2026 | Verkauf | 5.66 | 5,000 | 28,306 | Form 4 |
| SOPH | Jurgi Camblong | CEO | 04/20/2026 | Verkauf | 5.21 | 4,486 | 23,372 | Form 4 |
| SOPH | Kevin Puylaert | Insider | 04/20/2026 | Verkauf | 5.08 | 33 | 168 | Form 4 |
| SOPH | Manuela Valente | Insider | 04/20/2026 | Verkauf | 5.20 | 380 | 1,976 | Form 4 |
| SOPH | Philippe Menu | Insider | 04/20/2026 | Verkauf | 5.20 | 608 | 3,162 | Form 4 |
| SOPH | Ross Muken | President | 04/20/2026 | Verkauf | 5.20 | 760 | 3,952 | Form 4 |
| SOPH | Well Daan Van | Insider | 04/20/2026 | Verkauf | 5.20 | 684 | 3,557 | Form 4 |
| SOPH | Zhenyu Xu | Insider | 04/20/2026 | Verkauf | 5.21 | 608 | 3,168 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).